Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Iron deficiency and supplementation therapy in heart failure

More than 50% of patients with chronic heart failure present with iron deficiency, which is associated with reduced quality of life and worse prognosis. Intravenous iron supplementation therapy has been shown to improve clinical outcomes in these patients.

This is a preview of subscription content, access via your institution

Access options

Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.


  1. Mosterd, A. & Hoes, A. W. Clinical epidemiology of heart failure. Heart 93, 1137–1146 (2007).

    Article  Google Scholar 

  2. Klip, I. T. et al. Iron deficiency in chronic heart failure: an international pooled analysis. Am. Heart J. 165, 575–582.e3 (2013).

    CAS  Article  Google Scholar 

  3. Comín-Colet, J. et al. Iron deficiency is a key determinant of health-related quality of life in patients with chronic heart failure regardless of anaemia status. Eur. J. Heart Fail. 15, 1164–1172 (2013).

    Article  Google Scholar 

  4. Anker, S. D. et al. Ferric carboxymaltose in patients with heart failure and iron deficiency. N. Engl. J. Med. 361, 2436–2448 (2009).

    CAS  Article  Google Scholar 

  5. Ponikowski, P. et al. Beneficial effects of long-term intravenous iron therapy with ferric carboxymaltose in patients with symptomatic heart failure and iron deficiency. Eur. Heart J. 36, 657–668 (2015).

    CAS  Article  Google Scholar 

  6. Ponikowski, P. et al. Ferric carboxymaltose for iron deficiency at discharge after acute heart failure: a multicentre, double-blind, randomised, controlled trial. Lancet 396, 1895–1904 (2020).

    CAS  Article  Google Scholar 

  7. Hoes, M. F. et al. Iron deficiency impairs contractility of human cardiomyocytes through decreased mitochondrial function. Eur. J. Heart Fail. 20, 910–919 (2018).

    CAS  Article  Google Scholar 

  8. Tajes, M. et al. Neurohormonal activation induces intracellular iron deficiency and mitochondrial dysfunction in cardiac cells. Cell Biosci. 11, 89 (2021).

    CAS  Article  Google Scholar 

  9. McDonagh, T. et al. Screening, diagnosis and treatment of iron deficiency in chronic heart failure: putting the 2016 European Society of Cardiology heart failure guidelines into clinical practice. Eur. J. Heart Fail. 20, 1664–1672 (2018).

    CAS  Article  Google Scholar 

  10. US National Library of Medicine. (2020).

Download references


We thank the Multidisciplinary Community Heart Failure Unit and the Advanced Heart Failure and Heart Transplantation Unit of Bellvitge University Hospital for their daily work in improving the quality of life and prognosis of patients with HF.

Author information

Authors and Affiliations


Corresponding author

Correspondence to Josep Comin-Colet.

Ethics declarations

Competing interests

P.M. and J.C.-C. have received an unrestricted grant from Vifor Pharma for editorial support and open access of previous publications. J.C.-C. has received speaker fees from Vifor Pharma and belonged to the steering committees of the FAIR-HF, CONFIRM-HF and AFFIRM-HF trials.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Moliner, P., Comin-Colet, J. Iron deficiency and supplementation therapy in heart failure. Nat Rev Cardiol 19, 571–572 (2022).

Download citation

  • Published:

  • Issue Date:

  • DOI:


Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing